NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)
A Contract Award Notice
by NHS ENGLAND
- Source
- Contracts Finder
- Type
- Framework (Products)
- Duration
- 3 year
- Value
- £424M
- Sector
- HEALTH
- Published
- 14 May 2024
- Delivery
- 01 Jun 2024 to 31 May 2027
- Deadline
- 23 Nov 2023 13:00
Concepts
Location
1 buyer
- NHS England Runcorn
63 suppliers
- Accord Barnstaple
- Macure Pharma Aps Copenhagen
- Neon Healthcare Hertford
- Bristol Laboratories Berkhamsted
- Syri Ruislip
- Arcadia Pharma Swansea
- Kyowa Kirin Galashiels
- Waymade Basildon
- DR Falk Pharma Bourne End
- Lupin Healthcare Slough
- Crescent Pharma Basingstoke
- Derma Newcastle upon Tyne
- Chiesi Manchester
- Strides Pharma Watford
- Galvany Pharma Stevenage
- Phoenix Lab Clonee
- Drugsrus Harrow
- Aspen Pharmacare Paddington
- MSN Laboratories Europe Letchworth
- Scope Ophthalmics Crawley
- Stirling Anglian Pharmaceuticals Glasgow
- Eramol Sevenoaks
- Aop Orphan Birmingham
- Bayer Reading
- Krka Slough
- Thea Pharmaceuticals Newcastle under Lyme
- Relonchem Widnes
- Ferring Pharmaceuticals West Drayton
- Torrent Pharma Crawley
- JCSH Pharma Guildford
- Lundbeck Watford
- Takeda London
- Reckitt Benckiser Slough
- Strandhaven Ilford
- Synchrony Stevenage
- Brown & Burk Ruislip
- Tillomed Laboratories Luton
- Baxter Healthcare Newbury
- Galen Craigavon
- Reig Jofre Bideford
- Necessity Supplies Northolt
- Medley Pharma Liverpool
- Manx Healthcare Warwick
- Logixx Pharma Reading
- Evolan Pharma Danderyd
- Ascend Laboratories Edgware
- Rivopharm London
- Norgine Pharmaceuticals Harefield
- Vantage Pharmaceuticals Hemel Hempstead
- Cipla London
- Genesis Pharmaceuticals London
- Focus Pharmaceuticals London
- Correvio Bielefeld
- Beaumont Pharma Henley on Thames
- Typharm Norwich
- Oralieve Luton
- Orion Pharma Reading
- Recordati Pharmaceuticals Hemel Hempstead
- Clydesdale Pharma Tadley
- RPH Pharmaceuticals Cheadle
- Tetris Pharma Marlow
- PM Pharma Norwich
- Uni Health Distribution Dartford
Description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Award Detail
1 | Accord (Barnstaple)
|
2 | Macure Pharma Aps (Copenhagen)
|
3 | Neon Healthcare (Hertford)
|
4 | Bristol Laboratories (Berkhamsted)
|
5 | Syri (Ruislip)
|
6 | Arcadia Pharma (Swansea)
|
7 | Kyowa Kirin (Galashiels)
|
8 | Waymade (Basildon)
|
9 | DR Falk Pharma (Bourne End)
|
10 | Lupin Healthcare (Slough)
|
11 | Crescent Pharma (Basingstoke)
|
12 | Derma (Newcastle upon Tyne)
|
13 | Chiesi (Manchester)
|
14 | Strides Pharma (Watford)
|
15 | Galvany Pharma (Stevenage)
|
16 | Phoenix Lab (Clonee)
|
17 | Drugsrus (Harrow)
|
18 | Aspen Pharmacare (Paddington)
|
19 | MSN Laboratories Europe (Letchworth)
|
20 | Scope Ophthalmics (Crawley)
|
21 | Stirling Anglian Pharmaceuticals (Glasgow)
|
22 | Eramol (Sevenoaks)
|
23 | Aop Orphan (Birmingham)
|
24 | Bayer (Reading)
|
25 | Krka (Slough)
|
26 | Thea Pharmaceuticals (Newcastle under Lyme)
|
27 | Relonchem (Widnes)
|
28 | Ferring Pharmaceuticals (West Drayton)
|
29 | Torrent Pharma (Crawley)
|
30 | JCSH Pharma (Guildford)
|
31 | Lundbeck (Watford)
|
32 | Takeda (London)
|
33 | Reckitt Benckiser (Slough)
|
34 | Strandhaven (Ilford)
|
35 | Synchrony (Stevenage)
|
36 | Brown & Burk (Ruislip)
|
37 | Tillomed Laboratories (Luton)
|
38 | Baxter Healthcare (Newbury)
|
39 | Galen (Craigavon)
|
40 | Reig Jofre (Bideford)
|
41 | Necessity Supplies (Northolt)
|
42 | Medley Pharma (Liverpool)
|
43 | Manx Healthcare (Warwick)
|
44 | Logixx Pharma (Reading)
|
45 | Evolan Pharma (Danderyd)
|
46 | Ascend Laboratories (Edgware)
|
47 | Rivopharm (London)
|
48 | Norgine Pharmaceuticals (Harefield)
|
49 | Vantage Pharmaceuticals (Hemel Hempstead)
|
50 | Cipla (London)
|
51 | Genesis Pharmaceuticals (London)
|
52 | Focus Pharmaceuticals (London)
|
53 | Correvio (Bielefeld)
|
54 | Beaumont Pharma (Henley on Thames)
|
55 | Typharm (Norwich)
|
56 | Oralieve (Luton)
|
57 | Orion Pharma (Reading)
|
58 | Recordati Pharmaceuticals (Hemel Hempstead)
|
59 | Clydesdale Pharma (Tadley)
|
60 | RPH Pharmaceuticals (Cheadle)
|
61 | Tetris Pharma (Marlow)
|
62 | PM Pharma (Norwich)
|
63 | Uni Health Distribution (Dartford)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract is suitable for SMEs.
Other Information
Framework Agreement and Terms and Conditions - Wave 14c#2 Framework Agreement and Terms and Conditions - Wave 14c#2.pdf Transparency Award Schedule - Wave 14c Lot 1 5672_01#2 Transparency Award Schedule - Wave 14c Lot 1 5672_01#2.pdf Wave 14c Parties Appointed & SME Status#2 Wave 14c Parties Appointed & SME Status#2.xlsx Transparency Award Schedule - Wave 14c Lot 3 5672_03#2 Transparency Award Schedule - Wave 14c Lot 3 5672_03#2.pdf Transparency Award Schedule - Wave 14c Lot 2 5672_02#2 Transparency Award Schedule - Wave 14c Lot 2 5672_02#2.pdf
Reference
- CF-2353700D0O000000rwimUAA
- CF c3b17fe3-6ef4-4a0a-a5ef-4a4939328e53